학술논문

A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, February 2024, 103(2):475-488)
Subject
Language
English
ISSN
14320584
09395555